Skip to main content
S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%
Smart Investors Daily
SID Premium
SR

NASDAQ · SRTS

Sensus Healthcare, Inc.

Healthcare · Medical - Devices

$3.25

Down-$0.04 (-1.07%)

Updated Nov 5, 2026, 2:36 AM

SID Score

5.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
63.07M
P/E ratio
-20.86
Dividend yield
0.00%
52-week range
$2.66 – $5.25
Volume
474.14K
Avg. volume
108.12K

Price performance · SRTS

SRTS price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 4, 2026

SRTS closed at $3.25 after 21 trading sessions, up 10.54% for the selected period.

Last close
$3.25
Period change
+10.54%
Period low
$2.75
Period high
$3.29
Daily close
View OHLC price history
SRTS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 4, 2026$3.20$3.73$3.07$3.25474.14K
Nov 3, 2026$2.76$5.25$2.76$3.2859.74M
Nov 2, 2026$2.76$2.825$2.75$2.7513.21K
Oct 30, 2026$2.75$2.90$2.75$2.7627.77K
Oct 29, 2026$2.79$2.83$2.75$2.7717.64K
Oct 28, 2026$2.74$2.90$2.74$2.8298.53K
Oct 27, 2026$2.81$2.87$2.68$2.7960.81K
Oct 26, 2026$2.90$2.90$2.81$2.8219.37K
Oct 23, 2026$2.8999$3.04$2.8999$2.9512.5K
Oct 22, 2026$2.9286$2.9499$2.84$2.8710.38K
Oct 21, 2026$2.76$2.94$2.76$2.865.61K
Oct 20, 2026$2.78$2.89$2.73$2.7550.92K
Oct 19, 2026$2.76$2.8636$2.7206$2.7624.7K
Oct 16, 2026$2.73$2.835$2.73$2.7712.83K
Oct 15, 2026$2.85$2.87$2.71$2.7725.96K
Oct 14, 2026$2.89$2.9845$2.80$2.8610.4K
Oct 13, 2026$2.91$3.00$2.89$2.8918.41K
Oct 12, 2026$2.93$3.005$2.93$2.937.63K
Oct 9, 2026$2.97$3.04$2.93$2.9513.23K
Oct 8, 2026$2.92$3.04$2.92$2.9719.09K
Oct 7, 2026$2.9201$3.05$2.9201$2.945.92K

Latest SRTS news

The latest Smart Investors Daily articles mentioning SRTS.

Stock researchCompany · Overview

SRTS research

Overview

Company profile and research snapshot.

Company profile

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$10.00
Implied upside
—
Analysts
9
SRTS recent ratings
DateFirmRatingTarget
Aug 14, 2026Lake StreetBuy—
Feb 17, 2026Maxim GroupBuy—
Aug 12, 2025HC Wainwright & Co.Buy—
Aug 8, 2025Lake StreetBuy—
May 19, 2025Maxim GroupBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 26, 2026

Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base

BOCA RATON, Fla., February 26, 2026--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, introduces Sensus Link, a cloud-based software and connectivity solution intended to expand advanced operating capabilities across the Company’s SRT-100™ system installed base.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By